{
  "Variants Include": [
    {
      "Gene": "parkin",
      "variants": [
        {
          "HGVS": "N.D. (No transcript number provided in the literature, unable to standardize via API)",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "R",
            "alt": "P",
            "position": "42"
          },
          "Description in input context": "R42P"
        },
        {
          "HGVS": "N.D. (No transcript number provided in the literature, unable to standardize via API)",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "K",
            "alt": "A",
            "position": "48"
          },
          "Description in input context": "K48A"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Autosomal recessive juvenile Parkinson's disease",
    "MONDO": "MONDO:0005222"
  },
  "Experiment Method": [
    {
      "Assay Method": "Cloning",
      "Material used": {
        "Material Source": "DNA fragments, bacteria",
        "Material Name": "DNA fragment encoding Ubld of human parkin, pET44a vector, GEV1 vector, pET3a vector, BL21(DE3) Codon Plus Escherichia coli strain, BL21(DE3)pLysS Escherichia coli strain",
        "Description": "The DNA fragment encoding the Ubld (residues 1 - 77) of human parkin was cloned into the NdeI and BamHI sites of the pET44a vector. For expression with an in - frame N - terminal GB1 fusion the DNA fragment encoding the Ubld (1 - 77) was cloned into the NheI and XhoI sites of the GEV1 vector. Ubiquitin from Saccharomyces cereVisiae was expressed from a pET3a vector. All Ubld constructs, GB1, GB1 fusion proteins and mutants of ubiquitin were overexpressed in the BL21(DE3) Codon Plus Escherichia coli strain. Ubiquitin was expressed in the BL21(DE3)pLysS Escherichia coli strain."
      },
      "Readout type": "N.D.",
      "Readout description": [
        {
          "Variant": "N.D. (No HGVS nomenclature available)",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "N.D."
        },
        {
          "Variant": "N.D. (No HGVS nomenclature available)",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "N.D."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes (Cloning is a common method in genetic research related to Parkinson's disease)"
      }
    },
    {
      "Assay Method": "Protein Expression and Purification",
      "Material used": {
        "Material Source": "Bacteria",
        "Material Name": "BL21(DE3) Codon Plus Escherichia coli strain, BL21(DE3)pLysS Escherichia coli strain",
        "Description": "All Ubld constructs, GB1, GB1 fusion proteins and mutants of ubiquitin were overexpressed in the BL21(DE3) Codon Plus Escherichia coli strain. Ubiquitin was expressed in the BL21(DE3)pLysS Escherichia coli strain. The bacteria were grown in LB media or M9 minimal media with specific antibiotics and induced with IPTG at different growth stages."
      },
      "Readout type": "N.D.",
      "Readout description": [
        {
          "Variant": "N.D. (No HGVS nomenclature available)",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "N.D."
        },
        {
          "Variant": "N.D. (No HGVS nomenclature available)",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "N.D."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes (Protein expression and purification are standard methods in Parkinson's disease - related protein research)"
      }
    },
    {
      "Assay Method": "Protein Unfolding Experiments",
      "Material used": {
        "Material Source": "Proteins",
        "Material Name": "Parkin Ubld, ubiquitin, Ubld R42P, Ubld K48A, Ub R42P, Ub K48A",
        "Description": "Protein samples for unfolding experiments were prepared by combining aliquots from a series of protein stock solutions with appropriate dilutions of urea and buffer. Samples were equilibrated overnight at 5 °C."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "N.D. (No HGVS nomenclature available)",
          "Conclusion": "For K48A: Little effect on stability. For R42P in Ubld: Susceptible to degradation, indication of decreased stability. For R42P in Ub: Marked decrease in stability",
          "Molecular Effect": "For K48A: Little effect. For R42P in Ubld: Complete unfolding. For R42P in Ub: Decreased stability",
          "Result Description": "The K48A mutation had little effect on the stability of the parkin Ubld or ubiquitin. The R42P mutation in parkin's Ubld caused poor expression and degradation of the protein. The Ub R42P protein had a 3.6 M shift in its denaturation midpoint compared to wild - type Ub."
        },
        {
          "Variant": "N.D. (No HGVS nomenclature available)",
          "Conclusion": "See above",
          "Molecular Effect": "See above",
          "Result Description": "See above"
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "All unfolding experiments were conducted in duplicate."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "The chemical unfolding data recorded by circular dichroism spectropolarimetry were analyzed using the program GraphPad Prism version 4.0. The unfolding transitions were fit according to a two - state unfolding curve using specific equations."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes (Protein unfolding experiments are relevant for studying protein stability in Parkinson's disease research)"
      }
    },
    {
      "Assay Method": "NMR Spectroscopy",
      "Material used": {
        "Material Source": "Proteins",
        "Material Name": "15N - labeled Ubld, GB1, GB1 - Ubld, GB1 - Ubld R42P",
        "Description": "NMR experiments were performed on 15N - labeled Ubld, GB1, GB1 - Ubld and GB1 - Ubld R42P samples in a specific buffer at 25 °C."
      },
      "Readout type": "Qualitative (structural information from spectra)",
      "Readout description": [
        {
          "Variant": "N.D. (No HGVS nomenclature available)",
          "Conclusion": "For GB1 - Ubld: Ubld is well - folded. For GB1 - Ubld R42P: Ubld is unfolded",
          "Molecular Effect": "For R42P: Causes unfolding of Ubld",
          "Result Description": "The 1H - 15N HSQC spectrum of GB1 - Ubld showed well - dispersed peaks for both GB1 and Ubld, indicating the Ubld was well - folded. The 1H - 15N HSQC spectrum of GB1 - Ubld R42P had a group of peaks corresponding to unfolded Ubld R42P and well - dispersed peaks for the folded GB1 domain."
        },
        {
          "Variant": "N.D. (No HGVS nomenclature available)",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "N.D."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes (NMR spectroscopy is a common method for studying protein structure in Parkinson's disease research)"
      }
    },
    {
      "Assay Method": "Size Exclusion Chromatography",
      "Material used": {
        "Material Source": "Proteins",
        "Material Name": "GB1, GB1 - Ubld, GB1 - Ubld R42P",
        "Description": "All samples were prepared in a specific buffer and injected onto a Superdex 75 column."
      },
      "Readout type": "Qualitative (elution volume indicating protein size and state)",
      "Readout description": [
        {
          "Variant": "N.D. (No HGVS nomenclature available)",
          "Conclusion": "GB1 - Ubld R42P behaves like a larger species, indicating an unfolded or aggregated state",
          "Molecular Effect": "For R42P: Causes abnormal behavior in size exclusion",
          "Result Description": "GB1 - Ubld eluted at a smaller volume compared to GB1, while GB1 - Ubld R42P eluted at a much earlier volume, indicating it was behaving like a much larger species."
        },
        {
          "Variant": "N.D. (No HGVS nomenclature available)",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "N.D."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes (Size exclusion chromatography is a common method for studying protein size and aggregation in Parkinson's disease research)"
      }
    }
  ]
}